Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 106

1.

Protective actions of sex steroid hormones in Alzheimer's disease.

Pike CJ, Carroll JC, Rosario ER, Barron AM.

Front Neuroendocrinol. 2009 Jul;30(2):239-58. doi: 10.1016/j.yfrne.2009.04.015. Epub 2009 May 7. Review.

PMID:
19427328
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

The potential use of hormone-based therapeutics for the treatment of Alzheimer's disease.

Carroll JC, Rosario ER.

Curr Alzheimer Res. 2012 Jan;9(1):18-34. Review.

PMID:
22329650
[PubMed - indexed for MEDLINE]
3.

Sex hormones, aging, and Alzheimer's disease.

Barron AM, Pike CJ.

Front Biosci (Elite Ed). 2012 Jan 1;4:976-97. Review.

PMID:
22201929
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Gender, sex steroid hormones, and Alzheimer's disease.

Vest RS, Pike CJ.

Horm Behav. 2013 Feb;63(2):301-7. doi: 10.1016/j.yhbeh.2012.04.006. Epub 2012 Apr 19. Review.

PMID:
22554955
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Effects of sex hormones on Alzheimer's disease-associated β-amyloid oligomer formation in vitro.

Morinaga A, Ono K, Takasaki J, Ikeda T, Hirohata M, Yamada M.

Exp Neurol. 2011 Apr;228(2):298-302. doi: 10.1016/j.expneurol.2011.01.011. Epub 2011 Jan 31.

PMID:
21281631
[PubMed - indexed for MEDLINE]
6.

Testosterone regulation of Alzheimer-like neuropathology in male 3xTg-AD mice involves both estrogen and androgen pathways.

Rosario ER, Carroll J, Pike CJ.

Brain Res. 2010 Nov 4;1359:281-90. doi: 10.1016/j.brainres.2010.08.068. Epub 2010 Aug 31.

PMID:
20807511
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Androgen regulation of beta-amyloid protein and the risk of Alzheimer's disease.

Rosario ER, Pike CJ.

Brain Res Rev. 2008 Mar;57(2):444-53. Epub 2007 Jul 7. Review.

PMID:
17658612
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Alzheimer's disease: review of hormone therapy trials and implications for treatment and prevention after menopause.

Henderson VW.

J Steroid Biochem Mol Biol. 2014 Jul;142:99-106. doi: 10.1016/j.jsbmb.2013.05.010. Epub 2013 May 28. Review.

PMID:
23727128
[PubMed - indexed for MEDLINE]
10.
11.

Androgen cell signaling pathways involved in neuroprotective actions.

Pike CJ, Nguyen TV, Ramsden M, Yao M, Murphy MP, Rosario ER.

Horm Behav. 2008 May;53(5):693-705. doi: 10.1016/j.yhbeh.2007.11.006. Epub 2007 Nov 22. Review.

PMID:
18222446
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Continuous and cyclic progesterone differentially interact with estradiol in the regulation of Alzheimer-like pathology in female 3xTransgenic-Alzheimer's disease mice.

Carroll JC, Rosario ER, Villamagna A, Pike CJ.

Endocrinology. 2010 Jun;151(6):2713-22. doi: 10.1210/en.2009-1487. Epub 2010 Apr 21.

PMID:
20410196
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Brain levels of sex steroid hormones in men and women during normal aging and in Alzheimer's disease.

Rosario ER, Chang L, Head EH, Stanczyk FZ, Pike CJ.

Neurobiol Aging. 2011 Apr;32(4):604-13. doi: 10.1016/j.neurobiolaging.2009.04.008. Epub 2009 May 9.

PMID:
19428144
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Estrogen and Alzheimer's disease: the story so far.

Cholerton B, Gleason CE, Baker LD, Asthana S.

Drugs Aging. 2002;19(6):405-27. Review.

PMID:
12149049
[PubMed - indexed for MEDLINE]
15.

Estradiol and tamoxifen differentially regulate a plasmalemmal voltage-dependent anion channel involved in amyloid-beta induced neurotoxicity.

Herrera JL, Fernandez C, Diaz M, Cury D, Marin R.

Steroids. 2011 Aug;76(9):840-4. doi: 10.1016/j.steroids.2011.02.014. Epub 2011 Feb 25. Review.

PMID:
21354436
[PubMed - indexed for MEDLINE]
16.

Reproductive hormones modulate oxidative stress in Alzheimer's disease.

Barron AM, Fuller SJ, Verdile G, Martins RN.

Antioxid Redox Signal. 2006 Nov-Dec;8(11-12):2047-59. Review.

PMID:
17034349
[PubMed - indexed for MEDLINE]
17.

Menopause and mitochondria: windows into estrogen effects on Alzheimer's disease risk and therapy.

Henderson VW, Brinton RD.

Prog Brain Res. 2010;182:77-96. doi: 10.1016/S0079-6123(10)82003-5.

PMID:
20541661
[PubMed - indexed for MEDLINE]
18.

The estrogen myth: potential use of gonadotropin-releasing hormone agonists for the treatment of Alzheimer's disease.

Casadesus G, Garrett MR, Webber KM, Hartzler AW, Atwood CS, Perry G, Bowen RL, Smith MA.

Drugs R D. 2006;7(3):187-93. Review.

PMID:
16752944
[PubMed - indexed for MEDLINE]
19.

APOE modulates the effect of estrogen therapy on Aβ accumulation EFAD-Tg mice.

Kunzler J, Youmans KL, Yu C, Ladu MJ, Tai LM.

Neurosci Lett. 2014 Feb 7;560:131-6. doi: 10.1016/j.neulet.2013.12.032. Epub 2013 Dec 22.

PMID:
24368217
[PubMed - indexed for MEDLINE]
20.

Hippocampal estrogen beta-receptor immunoreactivity is increased in Alzheimer's disease.

Savaskan E, Olivieri G, Meier F, Ravid R, Müller-Spahn F.

Brain Res. 2001 Jul 27;908(2):113-9.

PMID:
11454321
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk